While comprehensive gene editing liberalization in the European Union still appears distant, individual countries are making research progress

Credit: Vassil Donev via EPA and EFE
Credit: Vassil Donev via EPA and EFE
Using the gene editing method researchers at the University of Milan have started field trials of a rice genotype that they developed to be resistant to the disease. Field trials are a pre-registration process in plant breeding. This genotype, developed within the framework of a research project in which the Sainsbury laboratory (England Norwich) and the Max-Planck Institute (Germany) are also involved, is actually the product of a gene editing process performed on the large grain Arborio variety suitable for risotto. Gene editing is the precise modification of plant genes without adding foreign DNA, which is a faster and more accurate process compared to traditional breeding methods.

This technique is actually the laboratory version of classical mutation breeding. As it is known, mutation is a spontaneous or purposeful change in one of the living genes. Nearly 4000 varieties improved by mutation methods have been registered in the world. Genome editing includes CRISPR and a number of new gene engineering methods. In these methods, there is no external gene transfer, as with GMOs. On the contrary, the targeted gene is muted with temporary DNA cutting enzymes applied, its effect is increased or decreased, that is, it is subjected to micro-mutation.

In plant breeding, new genotypes are constantly being developed using techniques such as classical hybridization, selection, mutation and polyploidy โ€“ and by introducing GMO (Genetically Modified Organisms) methods in the last 30 years. While the Gene Editing method (i.e. new breeding technique (NGT)) discovered in 2013 won the Nobel Prize for its discoverers, it also shortened the breeding period considerably.

The varieties developed with gene editing methods in the last few years include freshwater sea bream in Argentina in 2019, soybean with improved oil quality in the USA, chickpeas in India, which were developed in a short period of four years, sweet tomatoes in Japan, and coral fish in Japan. The first calf was cloned in Russia using CRISPR which eliminates the cow milk allergies.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

In the EU, genotypes developed with this method are treated the same as genetically modified products (GMO) in registration procedures. Hundreds of millions of euros are required for environmental and health testing of these genotype candidates, as is the case with GMOs, which is an expense small-scale companies cannot afford. Varieties developed with NGT are tested and registered in many countries, especially in the USA, according to the regulations applied to variety candidates developed through classical breeding, not within the scope of GMO. A European Seed Community officialโ€™s opinion on this issue is worth noting:

โ€œWe believe that this NBT with high added value for both the farmer and the society is a profitable and practical application. It is time for the EU high councils to reconsider the issue. We can also intervene politically in the matter.โ€

The perspective on gene editing methods varies from country to country. For example, the EU included the legislation regarding this method within the scope of GMO, virtually banning the cultivation of varieties developed with gene editing methods. Under pressure from various groups, the EU made a legislative change regarding the registration of varieties developed within the scope of gene NGT at the beginning of 2024. While the new legislation provides an opportunity for the registration of gene editing products applied in classical varieties (NGT1), it does not apply to products obtained by gene editing made in non-classical varieties (NGT2), such as GMO. Legality will come into force when approved by all EU states. Currently, nearly 40 candidate genotypes for registration in the EU are eagerly expecting the legal deadline.

The EUโ€™s attitude in biotechnology also has an impact on other countries who cannot make much progress on GMO or gene editing due to potential problems they would face in exporting agricultural products.ย  These countries need manyย years to develop the directives and research infrastructure required, and the lack of a holistic umbrella organization in developing countries makes things even more challenging.

Dr. Nazimi Aรงฤฑkgรถz is an analyst, and writer based out of Izmir, Turkey. He studied at the University of Ankara and recieved a Ph.D from Munich Technical University, he was also Professor Emeritus of plant breeding at Ege University. Follow Nazimi on Twitter @nazimiacikgoz

A version of this article was posted at No Chance to Food Crisis and is used here with permission

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screen Shot at AM
Facts & Fallacies Podcast: Right-wing politics bad for your health? Separating speculation from science
ChatGPT-Image-Jun-9-2026-01_11_37-PM
Turmeric supplements: More risks than benefits
newborn infant baby mother
Facts & Fallacies Podcast: The truth about vitamin K shots
Screenshot-2026-06-16-at-10.02.22-PM
Viewpoint: โ€˜Industrial foodโ€™ primerโ€”Challenging the dangerous delusions of the alternative food movement
ChatGPT Image Jun 16, 2026, 12_03_37 PM
Kennedy accused of trying to โ€˜bullyโ€™ science journal that retracted study linking vaccines to infant deaths
ChatGPT-Image-Jun-15-2026-11_00_13-AM-2
Glucosamine alert: Alzheimerโ€™s progresses faster among those taking the popular supplement
ChatGPT-Image-Jun-15-2026-12_13_41-PM
Viewpoint: Behind the effort to re-purpose the tobacco attack strategy to fight ultra-processed foods
Screenshot-2026-06-16-at-12.33.01-PM
Whoโ€™s responsible when AI lies? Google challenging court ruling that search results are not protected from legal liability
Screenshot-2026-06-16-at-11.23.32-AM
In a rebuke to RFK, Jr.โ€™s anti-vax crusade, journal retracts study claiming hepatitis B vaccineโ€“autism link
ChatGPT-Image-Jun-3-2026-04_29_13-PM
Viewpoint: While unvaccinated children are dying overseas, Congress challenges Trump and Kennedyโ€™s block on aid
Screenshot-2026-06-16-at-12.46.54-PM
Viewpoint: โ€œDead Wrongโ€โ€”Understanding healthcareโ€™s misinformation epidemic
Screenshot-2026-06-14-at-9.53.54-AM
Is the World Cup a perfect storm for the spread of infectious diseases?
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.